These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1836986)

  • 41. Evaluation of cilazapril versus captopril in patients with mild to moderate essential hypertension.
    Stevenson JG; Chideckel EW
    Clin Exp Hypertens; 1994 Mar; 16(2):179-96. PubMed ID: 8193609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
    Leonetti G; Salvetti A
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cilazapril, a new ACE inhibitor, in severe arterial hypertension].
    Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerreo MI; Flores Serrano AG; González Franco MF
    Arch Inst Cardiol Mex; 1991; 61(6):573-8. PubMed ID: 1838916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
    Krum H; Jackson B; Conway EL; Howes LG; Johnston CI; Louis WJ
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):451-7. PubMed ID: 1279292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cilazapril on vascular structure and function in essential hypertension.
    Kiowski W; Linder L; Nuesch R; Martina B
    Hypertension; 1996 Mar; 27(3 Pt 1):371-6. PubMed ID: 8698440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
    Sung SH; Wu TC; Lin SJ; Chen JW
    J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of angiotensin converting enzyme inhibition [Cilazapril] on blood pressure recording in hypertensive obstructive sleep apneic patients.
    Grote L; Heitmann J; Köhler U; Ploch T; Penzel T; Peter JH
    Blood Press; 1997 Jul; 6(4):235-41. PubMed ID: 9296311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
    Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
    Prager G; Klein P; Schmitt M; Prager R
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New, in Austria registered specialty drugs. Inhibace (cilazapril)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(6):178-82. PubMed ID: 1533738
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
    Hiwatari M; Abe K; Yoshinaga K; Saito T
    Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
    Neutel JM; Buckalew V; Chrysant SG; Mroczek WJ; Ruff DA; Weber M
    Am Heart J; 1999 Jan; 137(1):118-25. PubMed ID: 9878944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach.
    Pagani M; Pizzinelli P; Mariani P; Lucini D; di Michele R; Malliani A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S110-6. PubMed ID: 1382158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S; Di Pasquale P; Parrinello G; Tuttolomondo A; Follone G; Cardinale A; Ortoleva A; Giambanco F; Abruzzese G; Colomba D; Bologna P; Fernández P; Giubilato A; Valdes L; Albano V; Licata G
    Drugs Exp Clin Res; 2000; 26(4):125-31. PubMed ID: 11109512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
    Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of the new angiotensin-converting enzyme inhibitor cilazapril: a pilot study.
    Mulinari RA; Gouni I; Gavras I; Gavras H
    J Clin Pharmacol; 1988 Jul; 28(7):660-3. PubMed ID: 2975290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.